Clinical Trial

Pilot Observational Study of an Integrative Cure Stay Program

Study acronym: Via Shalva
Recruiting
View on ClinicalTrials.gov →
Summary
This pilot observational study evaluates the feasibility and acceptability of conducting a prospective study alongside the individualized integrative oncology cure stay program "Via Shalva" for breast and gynecological cancer survivors. The study further explores preliminary changes in patient-reported outcomes, physiological measures, and biological markers before and after the retreat and compared with a matched control group.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-02.
Trial Details
NCT Number NCT07398079
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Breast Cancer, Gynecologic Cancer
Enrollment 30 participants
Start Date 2025-10-06
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-22